Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People having their first pulmonary vein isolation (PVI) procedure, which is a treatment for an irregular heart rhythm condition
- People diagnosed with paroxysmal atrial fibrillation, meaning their irregular heart rhythm comes and goes rather than being constant
- People whose heart is beating in a normal, regular rhythm at the time of admission
- People whose doctor has determined they meet the medical criteria for a PVI procedure
Who may not be able to join:
- People whose left atrial heart chamber is smaller than 38mm or larger than 50mm in size
- People whose heart pumping function is below 40% (a measure of how well the heart is pumping blood)
- People who have a condition where the heart's natural pacemaker does not work properly on its own
- People with significant problems with the electrical signals that coordinate the heartbeat (confirm with trial site for specific details)
- People who have previously had a cardioneuroablation procedure (a specific type of heart procedure targeting nerve tissue)
- People who are pregnant
- People for whom blood-thinning medication is not medically suitable
- People who have any other medical reason that makes a PVI procedure unsuitable for them
- People with a known intolerance or sensitivity to atropine (a medication sometimes used during heart procedures)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Piotr Niewinski, MD, PhD, Wroclaw Medical University
Phone: +48 71 733 1112
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
difference in the rate of persistent parasympathetic modulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.